NDC 55289-649
MethylPREDNISolone 4 mg tablet
On the label: PD-Rx Pharmaceuticals, Inc.. It's repackaged: PD-Rx Pharmaceuticals, Inc. rebottles it from Par Health USA, LLC's NDC 0603-4593.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Generics Bidco II LLC d/b/a Prinston Laboratories | Charlotte, NC, United States | Makes it, packages it and labels it | Problems found, fixed voluntarilySep 19, 2025 · 10 inspections, 1 with FDA action |
| Par Formulations Private Limited | Chennai, India | Makes it, tests it and packages it | Problems found, fixed voluntarilyJun 10, 2026 · 7 inspections |
Repackaging site
- PD-Rx Pharmaceuticals Inc., Oklahoma City, OK, United States · repackages it
Recalls
- Sep 11, 2014 · Class III · Qualitest Pharmaceuticals
Subpotent; 6 month stability time point
Lots: 100 count: T147F13A, Exp. 05/2015; 21 count: S003M14, Exp. 05/2015
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Methylprednisolone: every company that makes it
- Form
- tablet, oral
- Strength
- 4 mg
- Approval
- ANDA ANDA040183
- On the market since
- Dec 22, 1998
- Package NDCs
55289-649-30- Official label
- DailyMed (National Library of Medicine), updated Aug 10, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?